Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

2-(2-phenylvinyl)-4-[4-methylpiperazin-1-yl)]-6-(5-methyl-2H-pyrazol-3-yl-amino)-pyrimidine L(+) tartrate salt

EU orphan designation number: EU/3/15/1544   
Active ingredient: 2-(2-phenylvinyl)-4-[4-methylpiperazin-1-yl)]-6-(5-methyl-2H-pyrazol-3-yl-amino)-pyrimidine L(+) tartrate salt
Indication: Treatment of hepatocellular carcinoma
Sponsor: Dr Ulrich Granzer
Mauerkircherstraße 105, 81925 München, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/08/2015 Orphan designation EMA/OD/087/15 (2015)5781 of 10/08/2015